reports
- Jonathan Moreland
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5...
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) WATERTOWN, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 146,880 shares of the Company’s common stock to one new employee (the “Inducement Grant”), with the gr...
C4 Therapeutics Presents Monotherapy Data Demonstrating Proof of Mecha...
C4 Therapeutics Presents Monotherapy Data Demonstrating Proof of Mechanism and Early Evidence of Proof of Concept From Ongoing CFT1946 Phase 1 Trial in BRAF V600 Mutant Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024 CFT1946 Is Well-Tolerated at All Dose Levels; No Dose-Limiting Toxicities CFT1946 Achieves Dose Proportional Pharmacokinetic Exposure; Successfully Degrades BRAF V600 Mutant Protein Early Evidence of CFT1946 Monotherapy Anti-Tumor Activity in Patients Who Have Progressed on or After BRAF Inhibitor Therapies; Majority of Patients ...
- Jonathan Moreland
PENN PENN NATIONAL GAMING INC.
PAYC PAYCOM SOFTWARE INC.
MTDR MATADOR RESOURCES COMPANY
GLP GLOBAL PARTNERS LP
CODI COMPASS DIVERSIFIED HOLDINGS
FIVN FIVE9 INC.
FRD FRIEDMAN INDUSTRIES INC.
APTV APTIV PLC
APPN APPIAN
ZM ZOOM VIDEO COMMUNICATIONS
ETON INC.
INBX ETON PHARMACEUTICALS
PET INHIBRX
LUNR INC.
SYRS WAG GROUP CO
PEO INTUITIVE MACHINES INC
XPER SYROS PHARMACEUTICALS INC.
PETROLEUM & RESOURCES CORPORATION
XPERI INC
- Jonathan Moreland
PSEC PROSPECT CAPITAL CORPORATION
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
MTDR MATADOR RESOURCES COMPANY
CTRN CITI TRENDS INC.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
MYRG MYR GROUP INC.
HLT HILTON WORLDWIDE HOLDINGS INC
CNX CONSOL ENERGY INC.
ZM ZOOM VIDEO COMMUNICATIONS
GRNT INC.
FTHY GRANIT SKOPKE
PFHC FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
GNLX PROFRAC HLDG CORP
NPWR GENELUX CORP
PEO NET POWER INC
PETROLEUM & RESOURCES CORPORATION
C4 Therapeutics Announces Delivery of Second Development Candidate to ...
C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen Milestone Results in $8 Million Payment to C4 Therapeutics WATERTOWN, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced it has successfully delivered a second development candidate to Biogen and earned an $8 million milestone payment. This marks the final development candidate under this strategic collaboration. “We are thrilled to deliver a highly catalytic...
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Cli...
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024 Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity Investor Webcast to be Held Friday, September 13, 2024 at 12:00 pm ET WATERTOWN, Mass., Sept. 08, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced the abstract sharing clinical data fr...
- Jonathan Moreland
C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, ...
C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors WATERTOWN, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced the continued evolution of its Board of Directors with the appointment of Stephen (Steve) Fawell, Ph.D. as a director. With this appointment, Malcolm Salter has decided to retire from the Board of Directors after nearly a decade of service. “We are excited to welcome Steve to th...
C4 Therapeutics to Participate in Upcoming September Investor Conferen...
C4 Therapeutics to Participate in Upcoming September Investor Conferences WATERTOWN, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in fireside chats at two September investor conferences. Fireside Chat Details: Event: Wells Fargo Healthcare Conference taking place in Boston, MADate/Time: September 5, 2024 at 8:45 AM ET Event: 2024 Cantor Global Healthcare Conference taking place in New York, N...
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
HNRG HALLADOR ENERGY CO.
FLDM FLUIDIGM
BEN FRANKLIN RESOURCES INC.
APEI AMERICAN PUBLIC EDUCATION
ATEC ALPHATEC HOLDINGS INC.
DKL DELEK LOGISTICS PARTNERS
BWFG BANKWELL FINANCIAL GROUP
GBDC GOLUB CAPITAL BDC INC.
APPN APPIAN
QNTO QUAINT OAK BANCORP INC.
ELAN ELANCO ANIMAL HEALTH INC.
U UNITY SOFTWARE INC.
ONEW ONEWATER MARINE
INBX INHIBRX
IMMX INC.
PFHC IMMIX BIOPHARMA INC
CALC PROFRAC HLDG CORP
ET CALCIMEDICA INC.
XPER ENERGY TRANSFER LP
NUTX XPERI INC
NUTEX HEALTH INC
- Jonathan Moreland
OEC ORION ENGINEERED CARBONS SA
ZM ZOOM VIDEO COMMUNICATIONS
GRX INC.
HYZN THE GABELLI HEALTHCARE & WELLNESSRX TRUST
BIGZ HYZON MOTORS INC.
VFC BLACKROCK INNOVATION AND GROWTH TST
MIO VF CORPORATION
PEO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
SUNS PETROLEUM & RESOURCES CORPORATION
SUNRISE REALTY TRUST
C4 Therapeutics Announces European Society for Medical Oncology (ESMO)...
C4 Therapeutics Announces European Society for Medical Oncology (ESMO) Changed the Previously Accepted CFT1946 Preliminary Phase 1 Abstract to a Proffered Paper Presentation Investor Webcast Moved to Friday, September 13, 2024 WATERTOWN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced the ESMO Congress decided to move C4T’s previously accepted preliminary monotherapy Phase 1 abstract for CFT1946, a novel BiDAC™ degrader in mutant BR...
- Jonathan Moreland
RHP RYMAN HOSPITALITY PROPERTIES INC.
PBPB POTBELLY CORP.
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
OEC ORION ENGINEERED CARBONS SA
NEOG NEOGEN CORPORATION
INTC INTEL CORPORATION
CRK COMSTOCK RESOURCES INC.
MEDP MEDPACE HOLDINGS INC.
NINE NINE ENERGY SERVICE INC
VCNX VACCINEX
PFIS PEOPLES FINANCIAL SERVICES CORP.
ZM ZOOM VIDEO COMMUNICATIONS
TSLX INC.
MPLN SIXTH STREET SPECIALTY LENDING
GEVO INC.
CTOS MULTIPLAN CORP CLASS A
RPID GEVO
GLSI CUSTOM TRUCK ONE SOURCE
INC.
RAPID MICRO BIOSYSTEMS INC
GREENWICH LIFESCIENCES INC
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
SIGI SELECTIVE INSURANCE GROUP INC.
SAIC SCIENCE APPLICATIONS INTERNATIONAL CORP.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
MXL MAXLINEAR INC
LKQ LKQ CORPORATION
FFIN FIRST FINANCIAL BANKSHARES INC
ACRS ACLARIS THERAPEUTICS INC.
CULP CULP INC.
NAD NUVEEN QUALITY MUNICIPAL INCOM
EVBN EVANS BANCORP INC.
LW LAMB WESTON HOLDINGS INC.
UBFO UNITED SECURITY BANCSHARE
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
ESQ ESQUIRE FINANCIAL HOLDINGS
AXR AMREP
FXNC FIRST NATIONAL CORP. OF VIRGINIA
VCNX VACCINEX
PFIS PEOPLES FINANCIAL SERVICES CORP.
REKR REKOR SYSTEMS
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
FNWB FIRST NORTHWEST BANCORP
AESE ALLIED ESPORTS ENTERTAINMENT
AZYO AZIYO BIOLOGICS
COFS CHOICEONE FINANCIAL SERVICES
TKNO ALPHA TEKNOVA
ADCT INC.
ACHR ADC THERAPEUTICS SA
ABIO ARCHER AVIATION INC
TPST ARCA BIOPHARMA INC
PET MILLENDO THERAPEUTICS
KMPH INC.
BIGZ WAG GROUP CO
DOUG KEMPHARM INC
LCTC BLACKROCK INNOVATION AND GROWTH TST
LUXH DOUGLAS ELLIMAN INC
FCCND LIFELOC TECHNOLOGIES INC
NE LUXURBAN HOTELS INC
STRW SPECTRAL CAPITAL CORP
ASPI NOBLE CORP (NEW)
MIO STRAWBERRY FIELDS REIT INC.
NUZE ASP ISOTOPES INC
BNED PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
DMA NUZEE INC.
MXF BARNES & NOBLE EDUCATION INC.
SSKN DESTRA MULTI ALTERNATIVE FUND
ADVM THE MEXICO FUND
NYC INC.
STRATA SKIN SCIENCES INC.
ADVERUM BIOTECHNOLOGIES INC.
NEW YORK CITY REIT
INC.
QUAINT OAK BANCORP, INC. ANNOUNCES SECOND QUARTER EARNINGS
QUAINT OAK BANCORP, INC. ANNOUNCES SECOND QUARTER EARNINGS Southampton, PA , Aug. 01, 2024 (GLOBE NEWSWIRE) -- Quaint Oak Bancorp, Inc. (the “Company”) (OTCQB: QNTO), the holding company for Quaint Oak Bank (the “Bank”), announced today net income for the quarter ended June 30, 2024 of $100,000, or $0.04 per basic and diluted share, compared to net income of $570,000, or $0.25 per basic and diluted share, net, for the same period in 2023. Net income for the six months ended June 30, 2024 of $973,000, or $0.39 per basic and diluted share, net, compared to net income of $1.1 million, or $0....
C4 Therapeutics Reports Second Quarter 2024 Financial Results and Rece...
C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights Preliminary Monotherapy Data from the Ongoing CFT1946 Phase 1 Trial in BRAF V600X Solid Tumors to be Presented at ESMO Congress 2024; Initiated Monotherapy Expansion Cohort in Melanoma and Combination Cohort with Cetuximab in Colorectal Cancer Cemsidomide Phase 1 Trial in Multiple Myeloma and non-Hodgkin’s Lymphoma Continues to Progress through Dose Escalation; Data on Track for Q4 2024 Cash, Cash Equivalents and Marketable Securities of $295.7 million as of June 30, 2024; Expected to Provide Runw...
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
SIGI SELECTIVE INSURANCE GROUP INC.
SAIC SCIENCE APPLICATIONS INTERNATIONAL CORP.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
AMSWA AMERICAN SOFTWARE INC. CL A
ACRS ACLARIS THERAPEUTICS INC.
CULP CULP INC.
NAD NUVEEN QUALITY MUNICIPAL INCOM
EVBN EVANS BANCORP INC.
FRD FRIEDMAN INDUSTRIES INC.
UBFO UNITED SECURITY BANCSHARE
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
PRPL PURPLE INNOVATION
FXNC INC.
REKR FIRST NATIONAL CORP. OF VIRGINIA
GRX REKOR SYSTEMS
AESE THE GABELLI HEALTHCARE & WELLNESSRX TRUST
TFC ALLIED ESPORTS ENTERTAINMENT
DMAC TRUIST FINANCIAL CORP
TSHA DIAMEDICA THERAPEUTICS INC.
TKNO TAYSHA GENE THERAPIES
AUID ALPHA TEKNOVA
IVFH INC.
ACHR IPSIDY INC.
ABIO INNOVATIVE FOOD HLDG
TPST ARCHER AVIATION INC
PET ARCA BIOPHARMA INC
KMPH MILLENDO THERAPEUTICS
BIGZ INC.
DOUG WAG GROUP CO
LCTC KEMPHARM INC
RH BLACKROCK INNOVATION AND GROWTH TST
LUXH DOUGLAS ELLIMAN INC
FCCND LIFELOC TECHNOLOGIES INC
NE RESTORATION HARDWARE HOLDINGS INC
STRW LUXURBAN HOTELS INC
ADCT SPECTRAL CAPITAL CORP
ASPI NOBLE CORP (NEW)
EP STRAWBERRY FIELDS REIT INC.
MIO ADC THERAPEUTICS SA
NUZE ASP ISOTOPES INC
BNED EMPIRE PETROLEUM CORP
DMA PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
ARDS NUZEE INC.
MXF BARNES & NOBLE EDUCATION INC.
SSKN DESTRA MULTI ALTERNATIVE FUND
ADVM ARIDIS PHARMACEUTICALS
NYC INC.
THE MEXICO FUND
INC.
STRATA SKIN SCIENCES INC.
ADVERUM BIOTECHNOLOGIES INC.
NEW YORK CITY REIT
INC.
- Jonathan Moreland
- Jonathan Moreland
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.